These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 38820022)

  • 21. Regional functional synchronizations in dementia with Lewy bodies and Alzheimer's disease.
    Peraza LR; Colloby SJ; Deboys L; O'Brien JT; Kaiser M; Taylor JP
    Int Psychogeriatr; 2016 Jul; 28(7):1143-51. PubMed ID: 26976496
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Translocator protein in late stage Alzheimer's disease and Dementia with Lewy bodies brains.
    Xu J; Sun J; Perrin RJ; Mach RH; Bales KR; Morris JC; Benzinger TLS; Holtzman DM
    Ann Clin Transl Neurol; 2019 Aug; 6(8):1423-1434. PubMed ID: 31402620
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gray matter atrophy in Parkinson disease with dementia and dementia with Lewy bodies.
    Beyer MK; Larsen JP; Aarsland D
    Neurology; 2007 Aug; 69(8):747-54. PubMed ID: 17709706
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An iTRAQ-based proteomic analysis reveals dysregulation of neocortical synaptopodin in Lewy body dementias.
    Datta A; Chai YL; Tan JM; Lee JH; Francis PT; Chen CP; Sze SK; Lai MKP
    Mol Brain; 2017 Aug; 10(1):36. PubMed ID: 28800743
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Focal atrophy in dementia with Lewy bodies on MRI: a distinct pattern from Alzheimer's disease.
    Whitwell JL; Weigand SD; Shiung MM; Boeve BF; Ferman TJ; Smith GE; Knopman DS; Petersen RC; Benarroch EE; Josephs KA; Jack CR
    Brain; 2007 Mar; 130(Pt 3):708-19. PubMed ID: 17267521
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe.
    Harding AJ; Broe GA; Halliday GM
    Brain; 2002 Feb; 125(Pt 2):391-403. PubMed ID: 11844739
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolic Network Topology of Alzheimer's Disease and Dementia with Lewy Bodies Generated Using Fluorodeoxyglucose Positron Emission Tomography.
    Imai M; Tanaka M; Sakata M; Wagatsuma K; Tago T; Toyohara J; Sengoku R; Nishina Y; Kanemaru K; Ishibashi K; Murayama S; Ishii K
    J Alzheimers Dis; 2020; 73(1):197-207. PubMed ID: 31771066
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Shared perturbations in the metallome and metabolome of Alzheimer's, Parkinson's, Huntington's, and dementia with Lewy bodies: A systematic review.
    Scholefield M; Unwin RD; Cooper GJS
    Ageing Res Rev; 2020 Nov; 63():101152. PubMed ID: 32846222
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Brain 3D-SSP SPECT analysis in dementia with Lewy bodies, Parkinson's disease with and without dementia, and Alzheimer's disease.
    Mito Y; Yoshida K; Yabe I; Makino K; Hirotani M; Tashiro K; Kikuchi S; Sasaki H
    Clin Neurol Neurosurg; 2005 Aug; 107(5):396-403. PubMed ID: 16023534
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heterogeneity in α-synuclein subtypes and their expression in cortical brain tissue lysates from Lewy body diseases and Alzheimer's disease.
    Vaikath NN; Erskine D; Morris CM; Majbour NK; Vekrellis K; Li JY; El-Agnaf OMA
    Neuropathol Appl Neurobiol; 2019 Oct; 45(6):597-608. PubMed ID: 30422353
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease.
    Rolinski M; Fox C; Maidment I; McShane R
    Cochrane Database Syst Rev; 2012 Mar; 2012(3):CD006504. PubMed ID: 22419314
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Performance on the dementia rating scale in Parkinson's disease with dementia and dementia with Lewy bodies: comparison with progressive supranuclear palsy and Alzheimer's disease.
    Aarsland D; Litvan I; Salmon D; Galasko D; Wentzel-Larsen T; Larsen JP
    J Neurol Neurosurg Psychiatry; 2003 Sep; 74(9):1215-20. PubMed ID: 12933921
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuropsychiatric symptoms and α-Synuclein profile of patients with Parkinson's disease dementia, dementia with Lewy bodies and Alzheimer's disease.
    Bougea A; Stefanis L; Paraskevas GP; Emmanouilidou E; Efthymiopoulou E; Vekrelis K; Kapaki E
    J Neurol; 2018 Oct; 265(10):2295-2301. PubMed ID: 30083953
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The influence of hippocampal atrophy on the cognitive phenotype of dementia with Lewy bodies.
    Elder GJ; Mactier K; Colloby SJ; Watson R; Blamire AM; O'Brien JT; Taylor JP
    Int J Geriatr Psychiatry; 2017 Nov; 32(11):1182-1189. PubMed ID: 28425185
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anomalies occurring in lipid profiles and protein distribution in frontal cortex lipid rafts in dementia with Lewy bodies disclose neurochemical traits partially shared by Alzheimer's and Parkinson's diseases.
    Marin R; Fabelo N; Martín V; Garcia-Esparcia P; Ferrer I; Quinto-Alemany D; Díaz M
    Neurobiol Aging; 2017 Jan; 49():52-59. PubMed ID: 27768960
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduction of RPT6/S8 (a Proteasome Component) and Proteasome Activity in the Cortex is Associated with Cognitive Impairment in Lewy Body Dementia.
    Alghamdi A; Vallortigara J; Howlett DR; Broadstock M; Hortobágyi T; Ballard C; Thomas AJ; O'Brien JT; Aarsland D; Attems J; Francis PT; Whitfield DR
    J Alzheimers Dis; 2017; 57(2):373-386. PubMed ID: 28269775
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Pathological and clinical comparison of Parkinson’s disease dementia and dementia with Lewy bodies].
    Bencs V; Bencze J; Módis VL; Simon V; Kálmán J; Hortobágyi T
    Orv Hetil; 2020 May; 161(18):727-737. PubMed ID: 32338488
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of ZnT3 and PSD95 protein levels in Lewy body dementias and Alzheimer's disease: association with cognitive impairment.
    Whitfield DR; Vallortigara J; Alghamdi A; Howlett D; Hortobágyi T; Johnson M; Attems J; Newhouse S; Ballard C; Thomas AJ; O'Brien JT; Aarsland D; Francis PT
    Neurobiol Aging; 2014 Dec; 35(12):2836-2844. PubMed ID: 25104558
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Longitudinal motor decline in dementia with Lewy bodies, Parkinson disease dementia, and Alzheimer's dementia in a community autopsy cohort.
    Choudhury P; Zhang N; Adler CH; Chen K; Belden C; Driver-Dunckley E; Mehta SH; Shprecher DR; Serrano GE; Shill HA; Beach TG; Atri A
    Alzheimers Dement; 2023 Oct; 19(10):4377-4387. PubMed ID: 37422286
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitative measurement of [Na+] and [K+] in postmortem human brain tissue indicates disturbances in subjects with Alzheimer's disease and dementia with Lewy bodies.
    Graham SF; Nasarauddin MB; Carey M; McGuinness B; Holscher C; Kehoe PG; Love S; Passmore AP; Elliott CT; Meharg A; Green BD
    J Alzheimers Dis; 2015; 44(3):851-7. PubMed ID: 25362038
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.